SCHEMBL3712175

SCHEMBL3712175

NCCCn1ccc2cnc(Cl)nc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAK1 Q13153 3/20 0.35
RPS6KA3 P51812 2/20 0.34
SIK1 P57059 1/20 0.32
SIK2 Q9H0K1 1/20 0.32
SIK3 Q9Y2K2 1/20 0.32
CDK4 P11802 3/20 0.32
CCND1 P24385 3/20 0.32
STAT6 P42226 1/20 0.31
GSK3B P49841 2/20 0.31
CDK1 P06493 2/20 0.31
AURKA O14965 1/20 0.31
DCLK1 O15075 1/20 0.31
PDPK1 O15530 1/20 0.31
JAK2 O60674 1/20 0.31
ROCK2 O75116 1/20 0.31
PRKD3 O94806 1/20 0.31
MAP4K4 O95819 1/20 0.31
EGFR P00533 1/20 0.31
NTRK1 P04629 1/20 0.31
PRKCG P05129 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27845067 0.84 RPS6KA3 (0.36) RPS6KA3STAT6PTK2KMT2A
SCHEMBL4187055 0.83 GLO1 (0.41) CDK4CCND1KMT2A
SCHEMBL28793690 0.81 RPS6KA3 (0.33) RPS6KA3STAT6PTK2KMT2A
SCHEMBL3712173 0.78 LMNA (0.49) RPS6KA3STAT6JAK2JAK3
SCHEMBL17066933 0.77 JAK2 (0.33) RPS6KA3CDK4CCND1STAT6GSK3B
SCHEMBL30881456 0.77 JAK2 (0.33) RPS6KA3CDK4CCND1STAT6GSK3B
SCHEMBL24150591 0.76 KMO (0.50) JAK2
SCHEMBL30019214 0.76 P2RX7 (0.41) RPS6KA3STAT6GSK3BCDK1AURKA
SCHEMBL3713449 0.74 LRRK2 (0.40) PAK1GSK3BCDK1
SCHEMBL30019422 0.74 STAT6 (0.41) RPS6KA3STAT6FYNSRCPTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2403853-B1 PYRROLOPYRIMIDINES USED AS KINASE INHIBITORS MEDICAL RES COUNCIL TECHNOLOGY (GB) 2013-08-14 EP disclosed
WO-2010100431-A1 PYRROLOPYRIMIDINES USED AS KINASE INHIBITORS MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) 2010-09-10 WO disclosed